Stolte M et al. |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male. |
1998 |
Z Gastroenterol |
pmid:9773482
|
Adamek RJ and Bethke TD |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. |
1998 |
Am. J. Gastroenterol. |
pmid:9772056
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Mukunda BN et al. |
Clarithromycin therapy for bacillary peliosis did not prevent bacillary angiomatosis. |
1998 |
Clin. Infect. Dis. |
pmid:9770180
|
Laine L et al. |
Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768532
|
Louw JA et al. |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768531
|
Pipkin GA et al. |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768524
|
Horgen L et al. |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium. |
1997 |
Res. Microbiol. |
pmid:9765852
|
Heald AE et al. |
Taste and smell complaints in HIV-infected patients. |
1998 |
AIDS |
pmid:9764787
|
Mégraud F and Doermann HP |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. |
1998 |
Gut |
pmid:9764043
|
Hawkey CJ et al. |
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. |
1998 |
Lancet |
pmid:9759744
|
Pontani D et al. |
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin. |
1998 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9758284
|
Kubas G and Gospodarek T |
[The use of clarithromycin and amoxycillin in pediatric acute otitis media]. |
1997 |
Otolaryngol Pol |
pmid:9757683
|
Denys A |
[Theoretical basis for the antibiotic therapy of the upper part of the respiratory system]. |
1997 |
Otolaryngol Pol |
pmid:9757681
|
Greenblatt DJ et al. |
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9757151
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|
Apseloff G et al. |
Comparison of azithromycin and clarithromycin in their interactions with rifabutin in healthy volunteers. |
1998 |
J Clin Pharmacol |
pmid:9753212
|
Huang WH et al. |
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection. |
1998 |
Zhonghua Yi Xue Za Zhi (Taipei) |
pmid:9745160
|
Hiratsuka T et al. |
[Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone]. |
1998 |
Nihon Kokyuki Gakkai Zasshi |
pmid:9742869
|
Sevin E et al. |
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. |
1998 |
FEMS Microbiol. Lett. |
pmid:9742711
|
Siu LK et al. |
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. |
1998 |
J. Clin. Microbiol. |
pmid:9738066
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Lamouliatte H et al. |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. |
1998 |
Am. J. Gastroenterol. |
pmid:9732938
|
Chu KM et al. |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. |
1998 |
Am. J. Gastroenterol. |
pmid:9732921
|
Vakil N et al. |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. |
1998 |
Am. J. Gastroenterol. |
pmid:9732920
|
Lanza FL et al. |
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer. |
1998 |
Helicobacter |
pmid:9731994
|
Bazzoli F et al. |
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. |
1998 |
Helicobacter |
pmid:9731991
|
Graham DY et al. |
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. |
1998 |
Helicobacter |
pmid:9731987
|
Barzilai A et al. |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. |
1998 |
Scand. J. Infect. Dis. |
pmid:9730300
|
Gorski JC et al. |
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9728893
|
Bermudez LE et al. |
Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice. |
1998 |
J. Infect. Dis. |
pmid:9728568
|
Bayoumi AM and Redelmeier DA |
Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. |
1998 |
AIDS |
pmid:9727572
|
Harris AW et al. |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726387
|
Pazzi P et al. |
Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726385
|
Sung JJ et al. |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726384
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|
Venuta A et al. |
Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. |
1998 Jun-Jul |
J. Int. Med. Res. |
pmid:9718470
|
Tanahashi T et al. |
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy. |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9715426
|
Cecchi R and Torelli E |
Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. |
1998 |
J. Dermatol. |
pmid:9714985
|
Améndola R et al. |
[Is dental plaque a normal Helicobacter pylori reservoir?]. |
1998 |
Acta Gastroenterol. Latinoam. |
pmid:9713656
|
Bergmann JS and Woods GL |
In vitro activity of antimicrobial combinations against clinical isolates of susceptible and resistant Mycobacterium tuberculosis. |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9712275
|
Fernández Bermejo M and GarcÃa Grávalos R |
[Ebrotidine in the eradicating treatment of H. pylori]. |
1998 Jun-Jul |
Gastroenterol Hepatol |
pmid:9711019
|
Burman WJ et al. |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. |
1998 |
AIDS |
pmid:9708410
|
van der Wouden EJ et al. |
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. |
1998 |
Am. J. Gastroenterol. |
pmid:9707042
|
Wang G et al. |
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. |
1998 |
J. Clin. Microbiol. |
pmid:9705423
|
Ellenrieder V et al. |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9701524
|
Takizawa H et al. |
Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. |
1998 |
Eur. Respir. J. |
pmid:9701415
|
Fennerty MB et al. |
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. |
1998 Aug 10-24 |
Arch. Intern. Med. |
pmid:9701099
|
Hsieh PF et al. |
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. |
1998 |
J. Formos. Med. Assoc. |
pmid:9700240
|
Wakasugi H et al. |
Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9695727
|
Hashimoto Y |
[Eradication therapies for Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9695480
|
Habu Y et al. |
Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan. |
1998 Jul-Aug |
Digestion |
pmid:9693202
|
Dobrilla G et al. |
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692703
|
Catalano F et al. |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692702
|
Bardhan KD et al. |
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9692693
|
Soepandi P et al. |
The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. |
1998 |
Respirology |
pmid:9692520
|
Bigard MA et al. |
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9690730
|
Portaels F et al. |
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9687409
|
Martin SJ and Pendland SL |
Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila. |
1998 |
J. Antimicrob. Chemother. |
pmid:9687103
|
Bordet AL et al. |
[Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. |
1997 |
Ann Dermatol Venereol |
pmid:9686059
|
Tonai A et al. |
[Clarithromycin suppression of DNA synthesis by rat nasal mucosal cells enhanced by endotoxin instillation]. |
1997 |
Jpn J Antibiot |
pmid:9678983
|
Grübel P and Cave DR |
Factors affecting solubility and penetration of clarithromycin through gastric mucus. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678818
|
Ahuja V et al. |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678815
|
Louw JA et al. |
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678814
|
Cammarota G et al. |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678813
|
Ricciardiello L et al. |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678812
|
Talley NJ et al. |
Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9678811
|
Perri F et al. |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. |
1998 |
Ital J Gastroenterol Hepatol |
pmid:9675647
|
Dunne EF et al. |
Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections. |
1998 |
Clin. Infect. Dis. |
pmid:9675460
|
Dore MP et al. |
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. |
1998 |
Clin. Infect. Dis. |
pmid:9675458
|
de Boer WA et al. |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9672338
|
Sanfélix Genovés J et al. |
[Helicobacter pylori: 6-day triple therapy in duodenal ulcer]. |
1998 |
Aten Primaria |
pmid:9670578
|
Miyaji H et al. |
Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663841
|
Kolkman JJ et al. |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663840
|
Goh KL et al. |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection? |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663838
|
Pozzato P et al. |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663724
|
Bazzoli F et al. |
Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663723
|
Spinzi GC et al. |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663722
|
Amsden GW et al. |
Oral cimetidine prolongs clarithromycin absorption. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9660986
|
Klein JO |
Clarithromycin and azithromycin. |
1998 |
Pediatr. Infect. Dis. J. |
pmid:9655546
|
Wiedermann BL |
Macrolides: clarithromycin and azithromycin. |
1998 |
Pediatr Rev |
pmid:9654947
|
Moshkowitz M et al. |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents. |
1998 |
Pediatrics |
pmid:9651466
|
Parente F et al. |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study. |
1998 |
Scand. J. Gastroenterol. |
pmid:9648983
|
Nakamura T et al. |
[Topics on Helicobacter pylori (discussion)]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648442
|
Sato R et al. |
[Problems following antibiotic therapy for eradication of Helicobacter pylori]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648440
|
Aoyama N |
[Efficacy of antibiotic therapy in eradicating Helicobacter pylori]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648439
|
Kimura K and Sato K |
[Recent topics on Helicobacter pylori--Historic background and problems caused by bacteria]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648427
|
Shimoyama T et al. |
[Antibiotic therapy in eradicating Helicobacter pylori infections]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9648426
|
Wharton JR et al. |
Erythrasma treated with single-dose clarithromycin. |
1998 |
Arch Dermatol |
pmid:9645634
|
Makhani S et al. |
Atypical cervico-facial mycobacterial infections in childhood. |
1998 |
Br J Oral Maxillofac Surg |
pmid:9643597
|
Grove DI et al. |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. |
1998 |
Pathology |
pmid:9643503
|
Gray VS |
Syncopal episodes associated with cisapride and concurrent drugs. |
1998 |
Ann Pharmacother |
pmid:9640482
|
Nordt SP et al. |
Clarithromycin induced digoxin toxicity. |
1998 |
J Accid Emerg Med |
pmid:9639187
|
Burman WJ et al. |
AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9635911
|
Calvet Calvo X |
[Treatment of Helicobacter pylori infections]. |
1998 |
Gastroenterol Hepatol |
pmid:9633184
|
Miwa H et al. |
Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population. |
1998 |
Helicobacter |
pmid:9631313
|
Battaglia G et al. |
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules. |
1998 |
Helicobacter |
pmid:9631310
|
Fireman Z et al. |
Helicobacter pylori and peptic ulcer disease therapies: a survey of gastroenterologists in Israel. |
1998 |
Helicobacter |
pmid:9631306
|
Domingo D et al. |
High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. |
1998 |
J. Antimicrob. Chemother. |
pmid:9630414
|